HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masashi Yoshida Selected Research

Postgastrectomy Syndromes

6/2022Effects of Proximal Gastrectomy and Various Clinical Factors on Postoperative Quality of Life for Upper-third Gastric Cancer Assessed using the Postgastrectomy Syndrome Assessment Scale-45 (PGSAS-45): A PGSAS NEXT Study.
5/2022Assessing optimal Roux-en-Y reconstruction technique after total gastrectomy using the Postgastrectomy Syndrome Assessment Scale-45.
11/2021Defecation disorders are crucial sequelae that impairs the quality of life of patients after conventional gastrectomy.
12/2018Background factors influencing postgastrectomy syndromes after various types of gastrectomy.
3/2017Quality of life after total vs distal gastrectomy with Roux-en-Y reconstruction: Use of the Postgastrectomy Syndrome Assessment Scale-45.
1/2015Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients.
6/2014Postgastrectomy Syndrome Assessment Scale (PGSAS)-45 and changes in body weight are useful tools for evaluation of reconstruction methods following distal gastrectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masashi Yoshida Research Topics

Disease

36Stomach Neoplasms (Stomach Cancer)
06/2022 - 01/2003
32Neoplasms (Cancer)
01/2022 - 01/2002
9Hemorrhage
01/2022 - 07/2002
9Carcinoma (Carcinomatosis)
10/2021 - 01/2003
7Postgastrectomy Syndromes
06/2022 - 06/2014
7Diabetes Mellitus
01/2022 - 01/2015
7Body Weight (Weight, Body)
06/2019 - 11/2013
6Esophageal Neoplasms (Esophageal Cancer)
10/2020 - 12/2011
6Type 2 Diabetes Mellitus (MODY)
07/2018 - 12/2010
5Pathologic Constriction (Stenosis)
05/2022 - 07/2002
5Duodenal Ulcer (Curling's Ulcer)
05/2022 - 12/2004
5Ulcer
12/2020 - 12/2004
5Cardiomegaly (Heart Hypertrophy)
10/2020 - 11/2009
5Hypertrophy
10/2020 - 08/2011
5Myocardial Infarction
09/2015 - 07/2002
4Insulin Resistance
03/2022 - 12/2010
4Heart Failure
03/2022 - 08/2011
4Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 01/2019
4Neoplasm Metastasis (Metastasis)
10/2021 - 01/2003
4Fibrosis (Cirrhosis)
01/2021 - 02/2014
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 07/2015
4Lymphatic Metastasis
04/2012 - 01/2003
3Cardiotoxicity
01/2022 - 11/2009
3Hypertension (High Blood Pressure)
11/2021 - 01/2020
3Prolapse
09/2021 - 01/2017
3Pulmonary Arterial Hypertension
01/2021 - 04/2017
3Anemia
01/2020 - 01/2011
3Surgical Wound Infection
07/2019 - 01/2016
3Placenta Previa
01/2019 - 01/2017
3Infections
05/2018 - 11/2008
3Glucose Intolerance
06/2016 - 12/2010
3Hyperglycemia
06/2016 - 10/2003
2Myocardial Ischemia (Ischemic Heart Diseases)
03/2022 - 09/2015
2Inguinal Hernia (Direct Inguinal Hernia)
01/2022 - 02/2017
2Sarcopenia
01/2022 - 11/2021
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022 - 12/2021
2Acute Coronary Syndrome
01/2022 - 07/2015
2Epstein-Barr Virus Infections
12/2021 - 12/2004
2Gallstones (Gallstone)
11/2021 - 02/2005
2Rectal Neoplasms (Rectal Cancer)
01/2021 - 07/2019
2Vomiting
01/2021 - 05/2020
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
10/2020 - 01/2019
2Aortitis
10/2020 - 01/2008
2Hypoglycemia (Reactive Hypoglycemia)
09/2020 - 03/2019
2Ileus
05/2020 - 03/2020
2Wounds and Injuries (Trauma)
01/2018 - 07/2004

Drug/Important Bio-Agent (IBA)

11Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2022 - 05/2005
10Glucose (Dextrose)FDA LinkGeneric
03/2022 - 10/2003
7Cisplatin (Platino)FDA LinkGeneric
05/2007 - 01/2003
6Insulin (Novolin)FDA Link
06/2019 - 11/2009
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2011 - 12/2004
5Cysteamine (Mercaptamine)FDA Link
11/2008 - 12/2004
4Biomarkers (Surrogate Marker)IBA
04/2022 - 07/2015
4Hemoglobins (Hemoglobin)IBA
01/2021 - 07/2015
4Immunoglobulins (Immunoglobulin)IBA
01/2021 - 12/2004
3Hemostatics (Antihemorrhagics)IBA
01/2022 - 12/2014
3Bisoprolol (Concor)FDA LinkGeneric
11/2021 - 08/2011
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 05/2019
3MonocrotalineIBA
01/2021 - 04/2017
3Epoprostenol (Prostacyclin)FDA LinkGeneric
11/2019 - 05/2013
3Pharmaceutical PreparationsIBA
05/2019 - 05/2007
3DNA (Deoxyribonucleic Acid)IBA
11/2009 - 12/2004
3Antineoplastic Agents (Antineoplastics)IBA
11/2007 - 01/2003
3Indicators and Reagents (Reagents)IBA
06/2005 - 07/2004
2Immune Checkpoint InhibitorsIBA
04/2022 - 09/2021
2NivolumabIBA
04/2022 - 10/2021
2Sodium-Glucose Transport ProteinsIBA
03/2022 - 05/2019
2Sodium-Glucose Transporter 2 InhibitorsIBA
03/2022 - 05/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 11/2009
2sacubitril and valsartan sodium hydrate drug combinationIBA
01/2022 - 01/2019
2Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2022 - 01/2019
2Neprilysin (Neutral Endopeptidase)IBA
01/2022 - 01/2019
2AntioxidantsIBA
01/2022 - 11/2009
2Immunoglobulin G (IgG)IBA
12/2021 - 10/2020
2Immunoglobulin M (IgM)IBA
12/2021 - 01/2013
2CalciumIBA
01/2021 - 07/2018
2pitavastatin (itavastatin)FDA Link
01/2020 - 11/2009
2Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2019 - 02/2003
2Coloring Agents (Dyes)IBA
01/2019 - 05/2005
2Angiotensin Receptor AntagonistsIBA
01/2019 - 01/2014
2Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2019 - 02/2014
2Eicosapentaenoic AcidIBA
08/2017 - 01/2017

Therapy/Procedure

32Gastrectomy
06/2022 - 01/2003
21Therapeutics
01/2021 - 01/2002
12Drug Therapy (Chemotherapy)
01/2022 - 01/2003
11Lymph Node Excision (Lymph Node Dissection)
10/2020 - 01/2003
6Esophagectomy
10/2021 - 02/2013
6Cesarean Section (Caesarean Section)
01/2019 - 01/2008
4Minimally Invasive Surgical Procedures
06/2022 - 01/2002
4Radiotherapy
10/2021 - 11/2003
3General Anesthesia
01/2022 - 06/2015
3Laparoscopic Cholecystectomy
11/2021 - 11/2018
3Sutures (Suture)
09/2021 - 01/2018
3Colostomy
01/2021 - 01/2016
3Surgical Instruments (Clip)
08/2020 - 01/2019
3Laparoscopes (Laparoscope)
01/2020 - 11/2018
3Chemoradiotherapy
11/2013 - 01/2003
3Combination Drug Therapy (Combination Chemotherapy)
08/2007 - 09/2005
2Length of Stay
09/2021 - 11/2013
2Negative-Pressure Wound Therapy
07/2019 - 01/2016